$RGBP Desmond, Earlier today I went to the Molecu
Post# of 373
Posted On: 05/09/2016 2:58:03 PM
Re: //Desmond// #264
$RGBP Desmond, Earlier today I went to the Molecuvax site and noticed that Harry Lander was CEO. A friend of mine just asked me about the situation, so I went on the site again. In the past several hours, Harry Lander's resume information was moved from (interim) CEO to a role on the scientific advisory board, with a resignation date as (interim) CEO being on 4/30/16. I do not have any other details to accompany this information. Here is the resume update from the Molecuvax site:
"Scientific Advisory Board
Harry Lander, Ph.D., MBA
Dr. Lander previously served as interim CEO of MVAX from January 01, 2016 to April 30, 2016 to assist Mr. Dixon with BORIS licensing agreement. Dr. Lander has voluntarily resigned to take the helm of our Scientific Advisory Board.
Dr. Lander has over 20 years of professional scientific, business and financial management experience related to biomedical research. Dr. Lander has extensive relationships with large and small biotechnology / pharmacology companies and entities that MolecuVax expects to leverage for company growth. Dr. Lander is currently President of Regen BioPharma, Inc. a publicly traded biotechnology company. Formerly he has served as Research Chief / Administration for Sidra Medical and Research Center (Doha, Qatar) and Assistant Provost for Weill Cornell Medical College (Cornell University)."
Source: http://molecuvax.com/?page_id=149
"Scientific Advisory Board
Harry Lander, Ph.D., MBA
Dr. Lander previously served as interim CEO of MVAX from January 01, 2016 to April 30, 2016 to assist Mr. Dixon with BORIS licensing agreement. Dr. Lander has voluntarily resigned to take the helm of our Scientific Advisory Board.
Dr. Lander has over 20 years of professional scientific, business and financial management experience related to biomedical research. Dr. Lander has extensive relationships with large and small biotechnology / pharmacology companies and entities that MolecuVax expects to leverage for company growth. Dr. Lander is currently President of Regen BioPharma, Inc. a publicly traded biotechnology company. Formerly he has served as Research Chief / Administration for Sidra Medical and Research Center (Doha, Qatar) and Assistant Provost for Weill Cornell Medical College (Cornell University)."
Source: http://molecuvax.com/?page_id=149
(0)
(0)Regen BioPharma Inc (RGBPD) Stock Research Links
Do your own DD. Assume everyone here is either an amateur trader/investor or a paid interest such as a compensated pumper/basher. My posts are strictly for entertainment purposes. I am not on Wall St., do not work for a group, and only get paid when my personal investments materialize. I am only responsible for my own gains and losses; no one is to blame for my mistakes or for any advice taken from postings; likewise, I am not to blame for any advice you take of mine, regardless of gains or losses from doing so. Good luck to all; may you live long and prosper greatly.
Scroll down for more posts ▼